Virtual opioid poisoning education and naloxone distribution programs: A scoping review
PLOS Digital Health · 07.06.2024 · 3 (6) · e0000412
DOI: 10.1371/journal.pdig.0000412 ↗Kurz gefasst
Scoping Review in der Zeitschrift PLOS Digital Health, online erschienen am 07.06.2024. Verfasst von Bruna Dos Santos und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dalla Lana School of Public Health, University of Toronto, Toronto, Canada. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Canada’s Substance Use and Addictions Program.
Abstract (Originalsprache)
The global opioid poisoning crisis is a complex issue with far-reaching public health implications. Opioid Poisoning Education and Naloxone Distribution (OPEND) programs aim to reduce stigma and promote harm reduction strategies, enhancing participants’ ability to apply life-saving interventions, including naloxone administration and cardiopulmonary resuscitation (CPR) to opioid poisoning. While virtual OPEND programs have shown promise in improving knowledge about opioid poisoning response, their implementation and evaluation have been limited. The COVID-19 pandemic has sparked renewed interest in virtual health services, including OPEND programs. Our study reviews the literature on fully virtual OPEND programs worldwide. We analyzed 7,722 articles, 30 of which met our inclusion criteria. We extracted and synthesized information about the interventions’ type, content, duration, the scales used, and key findings. Our search shows a diversity of interventions being implemented, with different study designs, duration, outcomes, scales, and different time points for measurement, all of which hinder a meaningful analysis of interventions’ effectiveness. Despite this, virtual OPEND programs appear effective in increasing knowledge, confidence, and preparedness to respond to opioid poisoning while improving stigma regarding people who use opioids. This effect appears to be true in a wide variety of populations but is significantly relevant when focused on laypersons. Despite increasing efforts, access remains an issue, with most interventions addressing White people in urban areas. Our findings offer valuable insights for the design, implementation, and evaluation of future virtual OPEND programs.
Autor:innen und Institutionen
- Dalla Lana School of Public Health, University of Toronto, Toronto, Canada.
- Heart to Heart First Aid CPR Services Inc., Toronto, Canada.
- Canadian Red Cross Opioid Harm Reduction Advisory Council, Canada.
- The Canadian Red Cross Society, Canada.
- Department of Family and Community Medicine, University of Toronto, Toronto, Canada.
- Li Ka Shing Knowledge Institute of Unity Health Toronto, Toronto, Canada.
ORCID-Profile: Bruna Dos Santos
Förderung
- Health Canada’s Substance Use and Addictions Program
Zitieren
APA
Dos Santos, B., Farzan Nipun, R., Maria Subic, A., Kubica, A., Rondinelli, N., Marentette, D., Muise, J., Paes, K., Riley, M., Bhuiya, S., Crosby, J., McBride, K., Salter, J., & Orkin, A. M. (2024). Virtual opioid poisoning education and naloxone distribution programs: A scoping review. PLOS Digital Health, 3(6), e0000412. https://doi.org/10.1371/journal.pdig.0000412
Vancouver
Dos Santos B, Farzan Nipun R, Maria Subic A, Kubica A, Rondinelli N, Marentette D, et al. Virtual opioid poisoning education and naloxone distribution programs: A scoping review. PLOS Digital Health. 2024;3(6):e0000412. doi:10.1371/journal.pdig.0000412
BibTeX
@article{DosSantos2024,
author = {Dos Santos, Bruna and Farzan Nipun, Rifat and Maria Subic, Anna and Kubica, Alexandra and Rondinelli, Nick and Marentette, Don and Muise, Joanna and Paes, Kevin and Riley, Meghan and Bhuiya, Samiya and Crosby, Jeannene and McBride, Keely and Salter, Joe and Orkin, Aaron M},
title = {Virtual opioid poisoning education and naloxone distribution programs: A scoping review},
journal = {PLOS Digital Health},
year = {2024},
volume = {3},
number = {6},
pages = {e0000412},
doi = {10.1371/journal.pdig.0000412}
}
EUVIMED